| 68.25 Delayed Data As of Jul 18 |  -0.07 / -0.10%Today’s Change | 65.06 Today|||52-Week Range 100.23 | -25.97% Year-to-Date |
| Previous close | 68.32 |
| Today’s open | 68.57 |
| Day’s range | 68.00 - 68.95 |
| Volume | 8,573,306 |
| Average volume (3 months) | 7,988,680 |
| Market cap | $103.8B |
| Earnings growth (last year) | +10.88% |
| Earnings growth (this year) | +11.09% |
| Earnings growth (next 5 years) | +5.67% |
| Revenue growth (last year) | +16.08% |
| P/E ratio | 19.1 |
| Price/Sales | 4.35 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | +0.27 | +0.66% |
| SNYSanofi | +0.38 | +0.91% |
| LLYEli Lilly and Co | +1.25 | +1.17% |
| AZNAstraZeneca | +0.39 | +0.97% |
| Next reporting date | July 26, 2019 |
| EPS forecast (this quarter) | $2.20 |
| Annual revenue (last year) | $32.8B |
| Annual profit (last year) | $5.7B |
| Net profit margin | 17.27% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Richard A. Gonzalez |
Vice Chairman & President Michael E. Severino |
Corporate headquarters North Chicago, Illinois |
